New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ...

Charlotte Elwood was diagnosed with a rare ovarian cancer in 1997 and given six months to live. She received multiple ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

Amidst global market turbulence, Asian markets have shown resilience, with Japan's stock indices experiencing modest gains and China's markets buoyed by stimulus hopes. In such an environment, ...

AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits ...

A TROP2-directed antibody-drug conjugate, DB-1305/BNT325, demonstrated durable activity in patients with previously treated ovarian cancer in a first-in-human trial. These results were presented at ...

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of ...

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced an agreement with Claritev, Inc. ("Claritev") (NYSE: CTEV), previously MultiPlan, ...

On Tuesday, Merck & Co (NYSE: MRK) Inc. emerged victorious in a significant legal dispute concerning its Gardasil vaccine, which is designed to prevent cervical and other serious cancers. U.S.

Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...

Verastem's assets, Avutometinib and Defactinib, show promising results in treating KRAS-mutated LGSOC. Read why VSTM stock is a Hold.